AMEPPI
Live / Allowed — Second extension granted (statement of use) (as of 16 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99211596
- Mark type
- Word mark
- Filed
- 30 May 2025
- Published for opposition
- 12 Aug 2025
- Attorney of record
- Deborah Liu Corpus
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of anaphylaxis; Pharmaceutical preparations for the treatment of allergic reactions, namely, emergency treatment of Type I allergic reactions; Pharmaceutical preparations for the treatment of low blood pressure, intraocular pressure and broncho-constriction
Owner
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
Prosecution history
- 16 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2026 — SOU EXTENSION 2 GRANTED
- 15 Sept 2026 — SOU EXTENSION 2 FILED
- 15 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Apr 2026 — SOU EXTENSION 1 GRANTED
- 06 Apr 2026 — SOU EXTENSION 1 FILED
- 06 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Aug 2025 — PUBLISHED FOR OPPOSITION
- 06 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2025 — ASSIGNED TO EXAMINER
- 30 May 2025 — APPLICATION FILING RECEIPT MAILED